INTEREST PURCHASE AGREEMENTInterest Purchase Agreement • November 12th, 2015 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This Interest Purchase Agreement (this “Agreement”) is entered into as of the 28th day of August, 2015 by and between Healthspan Research LLC, a Delaware limited liability company (the “Company”), and the undersigned investor (the “Investor”).
T +1 410.531.4000 W. R. Grace & Co.-Conn. 7500 Grace Drive Columbia, MD 21044ChromaDex Corp. • November 12th, 2015 • Medicinal chemicals & botanical products
ChromaDex, Inc. (“ChromaDex”) currently purchases nicotinamide riboside chloride (the “Product”) from W. R. Grace & Co.-Conn. (“Grace”) under terms agreed to by both ChromaDex and Grace. Notwithstanding any such terms, ChromaDex and Grace agree that the following purchase obligation and related terms shall apply, effective as of the date of this letter agreement:
LIMITED LIABILITY COMPANY AGREEMENT OF HEALTHSPAN RESEARCH, LLC Dated as of August 28, 2015Limited Liability Company Agreement • November 12th, 2015 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
THIS LIMITED LIABILITY COMPANY AGREEMENT, is entered into as of August 28, 2015, by and among the Members (as defined below) and the Company (as defined below).
EXCLUSIVE SUPPLY AGREEMENTExclusive Supply Agreement • November 12th, 2015 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
THIS SUPPLY AGREEMENT (the “Agreement”), is made and entered into as of August 28, 2015 (the “Effective Date”) by and between Healthspan Research LLC, a Delaware limited liability company, with principal offices located at 3130 Wilshire Blvd., 4th Floor, Santa Monica, California 90403 (“Buyer”) and ChromaDex Inc., a California corporation, with principal offices located at 10005 Muirlands, Blvd, Suite G, Irvine, CA 92618, USA (“Seller”).
